Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleNEUROPHARMACOLOGY

[Nphe1]NC(1-13)NH2 Selectively Antagonizes Nociceptin/Orphanin FQ-Stimulated G-Protein Activation in Rat Brain

Hartmut Berger, Girolamo Calo', Erika Albrecht, Remo Guerrini and Michael Bienert
Journal of Pharmacology and Experimental Therapeutics August 2000, 294 (2) 428-433;
Hartmut Berger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Girolamo Calo'
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erika Albrecht
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Remo Guerrini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Bienert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

[Phe1psi(CH2-NH)Gly2]noc/OFQ(1-13)-amide {[F/G]NC(1-13)NH2} and acetyl-RYYRIK-amide (Ac-RYYRIK-NH2), two peptidic ligands of the nociceptin/orphanin FQ (noc/OFQ) receptor, have been shown to exert both agonist and antagonist activity in different in vitro and in vivo systems. This is despite the observation that both peptides competitively antagonized the coupling of the activated receptor to G-proteins in brain preparations, measured in GTPγ35S binding assays. In this study, [Nphe1]NC(1-13)-amide ([Nphe1]NC(1-13)NH2), a new noc/OFQ analog recently characterized as a pure and selective noc/OFQ receptor antagonist in several in vitro and in vivo assay systems, was shown to competitively inhibit the noc/OFQ-stimulated GTPγ35S binding to rat cerebral cortex membranes with pA2 of 7.76 (Schild analysis). This antagonism of noc/OFQ receptor G-protein coupling was selective because the peptide inhibited the noc/OFQ-evoked GTPγ35S binding to rat brain membranes but not that evoked by selective agonists of the μ-, δ-, and κ-opioid receptors. In rat cortical membranes, the effects of [F/G]NC(1-13)NH2 and Ac-RYYRIK-NH2 on the binding of GTPγ35S were clearly differentiated from the effect of [Nphe1]NC(1-13)NH2 when the concentration of GDP, competing with GTPγS for binding, was lowered from 100 μM (assay optimum) to 5 μM. At 5 μM GDP, the former peptides showed clear partial agonist activity, whereas [Nphe1]NC(1-13)NH2 did not. These data indicate that only [Nphe1]NC(1-13)NH2 was a pure antagonist of noc/OFQ receptor G-protein coupling. Furthermore, it is suggested that the variable behavior of [F/G]NC(1-13)NH2 and Ac-RYYRIK-NH2 (agonist, partial agonist, and antagonist) in different in vitro and in vivo systems may be explained by different partial GTP binding agonism and the existence of a GTP binding stimulus/response reserve (coupling reserve).

Footnotes

  • Send reprint requests to: Dr. Hartmut Berger, Institute of Molecular Pharmacology, Alfred-Kowalke-Str. 4, D-10315 Berlin, Germany. E-mail: berger{at}fmp-berlin.de

  • Abbreviations:
    ORL1
    opioid receptor-like 1
    noc/OFQ
    nociceptin/orphanin FQ
    Ac-RYYRIK-NH2
    acetyl-RYYRIK-amide
    [F/G]NC(1-13)NH2
    [Phe1psi(CH2-NH)Gly2]noc/OFQ(1-13)-amide
    GPCR
    G-protein-coupled receptor
    Noc/OFQ
    nociceptin/orphanin FQ
    [Nphe1]NC(1-13)NH2
    [Nphe1]noc/OFQ(1-13)-amide
    CHO
    Chinese hamster ovary
    • Received December 22, 1999.
    • Accepted April 25, 2000.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 294 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 294, Issue 2
1 Aug 2000
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
[Nphe1]NC(1-13)NH2 Selectively Antagonizes Nociceptin/Orphanin FQ-Stimulated G-Protein Activation in Rat Brain
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleNEUROPHARMACOLOGY

[Nphe1]NC(1-13)NH2 Selectively Antagonizes Nociceptin/Orphanin FQ-Stimulated G-Protein Activation in Rat Brain

Hartmut Berger, Girolamo Calo', Erika Albrecht, Remo Guerrini and Michael Bienert
Journal of Pharmacology and Experimental Therapeutics August 1, 2000, 294 (2) 428-433;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleNEUROPHARMACOLOGY

[Nphe1]NC(1-13)NH2 Selectively Antagonizes Nociceptin/Orphanin FQ-Stimulated G-Protein Activation in Rat Brain

Hartmut Berger, Girolamo Calo', Erika Albrecht, Remo Guerrini and Michael Bienert
Journal of Pharmacology and Experimental Therapeutics August 1, 2000, 294 (2) 428-433;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • KRM-II-81 Analogs
  • Substituted Tryptamine Activity at 5-HT Receptors and SERT
  • VTA muscarinic M5 receptors and effort-choice behavior
Show more Neuropharmacology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics